alcohol and glp 1 medications A new clinical trial supported by the National Institutes of Health (NIH) found that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals GLP-1s Hold Promise as Treatment

Fatigue, sleep disruptions , and temperature sensitivity are also reported by some users, particularly during dose adjustments

USA 89 , 86418645 (1992)

Bone broth The bone broth trend has been going strong for over a decade for good reason

Hunter explained how Alzheimers disease begins with amyloid plaques and explained that microglia play a role in the steps that lead to brain cells dying. The doctor also said that different trials are just to see how well GLP-1 drugs can help treat Alzheimers disease and that the drug that is closest to FDA [Food and Drug Administration] approval is semaglutide. Hunter expected that UTHealths own EVOKE trial will announce results on the use of semaglutide for Alzheimers in the fall of 2025